Quick Links
Past Events

Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by educational grants from AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb, Celgene Corporation, Clovis Oncology, Genentech, Lilly, Merck, Inc., and Novartis Oncology.

For further information concerning Lilly grant funding visit
Privacy Policy
Terms & Conditions
Executive Board
Faculty Portal
Google +
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2018
Physicians’ Education Resource ®, LLC.
All rights reserved.

9th Annual New York Lung Cancer Symposium®

9th Annual New York Lung Cancer Symposium®


Saturday, November 8, 2014
7:00 AM Registration and Breakfast  
8:00 AM Welcome, Introductions, and Pre-Session Survey  
Challenges and New Directions in Molecular-Targeted Therapy Moderators: Roman Perez-Soler, MD and Gregory Riely, MD, PhD
8:15 AM How I Manage Acquired Resistance to EGFR TKIs Thomas J. Lynch, MD
8:35 AM Managing Oligoprogression During Therapy with EGFR or ALK TKIs Gregory Riely, MD, PhD
  Debate: EGFR TKIs Have a Role in the Adjuvant Setting  
8:55 AM Pro Jamie E. Chaft, MD
9:10 AM Con Balazs Halmos, MD
9:25 AM How New Molecular Diagnostic Platforms Will Change Diagnosis and Treatment of Lung Cancers Maria E. Arcila, MD
9:45 AM Question-and-Answer Session  
9:55 AM Break
Angiogenesis and Immunotherapy: Changes That Will Impact Your Practice Moderators: Jorge E. Gomez, MD and Bryan J. Schneider, MD
10:20 AM New Opportunities for Antiangiogenic Agents in Lung Cancers Benjamin P. Levy, MD
10:40 AM Incorporation of Immunotherapy in Lung Cancers: How Far Have We Come in 2014? Roy S. Herbst, MD, PhD
11:00 AM Question-and-Answer Session  
11:10 AM Post-Session Survey  
11:15 AM Challenging Cases in Lung Cancers Moderators: Abraham Chachoua, MD and Harry Raftopoulos, MD
Panelists: Harry D. Harper, MD
11:50 AM Lunch
New Approaches for Small-Cell and Squamous Lung Cancers Moderators: Abraham Chachoua, MD and Steven E. Vogl, MD
1:20 PM Pre-Session Survey  
1:25 PM What Are My Options When Squamous-Cell Lung Cancers Are the Target? Peter Hammerman, MD, PhD
1:45 PM Moving Forward With Small-Cell Lung Cancers Christine L. Hann, MD, PhD
2:05 PM Question-and-Answer Session  
2:15 PM Even More Challenging Cases in Lung Cancers Moderators: Jorge E. Gomez, MD and Bryan J. Schneider, MD
Panelists: Jeffrey G. Schneider, MD
2:50 PM Break  
2014 Best Practices in Lung Cancers Moderators: Harry Raftopoulos, MD and Benjamin P. Levy, MD
3:15 PM The Changing Landscape of Therapy for Patients with ALK-Positive Lung Cancers Gregory Riely, MD, PhD
3:35 PM Neoadjuvant vs Adjuvant Therapy for Patients with Lung Cancers Mark G. Kris, MD
3:55 PM What Are the Roles of Chemotherapy in the Molecular Age? Richard J. Gralla, MD
  Debate: Is There an Optimal Approach for EGFR-Mutant Lung Cancers?
4:15 PM Yes Balazs Halmos, MD
4:30 PM No Roman Perez-Soler, MD
4:45 PM Question-and-Answer Session  
4:55 PM Post-Session Survey  
5:00 PM Closing Remarks and Adjourn  

Become a Member

Forgot Password?
Calendar of Events
Filter By